The SURMOUNT-1 trial (tirzepatide, published in NEJM 2022) demonstrated that participants with obesity or overweight without diabetes who received tirzepatide experienced weight reductions of 16.0% (5mg), 21.4% (10mg), and 22.5% (15mg) over 72 weeks
However, curcumin suffers from extremely poor bioavailability
Tracking your cycle using a calendar or period-tracking app during the first six months of treatment helps you and your provider distinguish expected adaptation from abnormal patterns that warrant investigation
Peptides that modulate immune function are intervening in a system that is already malfunctioning
L'extrapolation de ces doses l'humain, en utilisant les facteurs de conversion allomtriques standard (facteur de 6,2 pour le rat), donne des doses thoriques de l'ordre de 1,6 g/kg chez l'humain
labs, with every lot tested for 99% purity and endotoxin-free status